Wave Life Sciences (WVE) said in a regulatory filing that it considers its direct exposure to SVB’s (SIVB) receivership as immaterial, given that the aggregate amount of the company’s cash and restricted cash held at SVB is approximately $1.5M, which is $1.25M in excess of the FDIC-insured amount of $250,000.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WVE: